- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Sunrest Lifescience has announced a board meeting that approved the consolidated financial results for the quarter and half-year. Revenue grew to ₹33.12 Cr from ₹29.48 Cr, while profit before tax jumped impressively to ₹2.61 Cr versus ₹0.59 Cr last year. Operating cash flow remained healthy at ₹1.43 Cr despite cash outflows from investing and financing. The company boosted trade payables and borrowings to support working capital. A clean audit report underlines strong financial health as Sunrest consolidates operations for the first time.